Résumé -Cet article s'intéresseà la classification automatique de cellules de l'épithélium pavimenteux pour le depistage cancer du col de l'utérus en s'appuyant sur les outils de l'apprentissage profond. Nousétudions differentes architectures sur un jeu de données public nommé Herlev qui consisteà classifier des images de cellules, issues d'un frottis du col de l'utérus, au regard de l'anormalité qu'elles représentent. De plus, nous utilisons et adaptons une méthode d'attribution afin de mettre en lumière les caratéristiques cytomorphologiques discriminantes qui sont utilisées pour la classification. A travers cet article, nous détaillerons les methodes et architectures qui nous permettent d'atteindre des performances optimisées: 74.5% de précision pour la classification de la sévérité et 94% pour la classification de la normalité.
Introduction
The World Health Organization (WHO) states [1] that around 90% of cervical cancer could be avoided if they were detected and treated earlier. At 500 × 10 3 new cases per year, screening for cervical cancer needs to be efficient and precise.
With the recent emergence of machine learning using deep Convolutional Neural Networks (CNN) and its success on a large panel of tasks, a lot of work has been done to assist doctors and medical practices [2, 3] using such methods. In the case of cervical cancer, the Herlev public dataset enables to compare different methods on this specific task by providing images of single cells and organizing them into classes regarding the malignancy they represent.
In this paper, we will firstly exploit the ordinal nature of the WHO classification present in the Herlev dataset, by designing a loss function that leads to a training paradigm that closely resembles the medical task at hand. Finally we will apply attribution methods to determine what cytomorphological features are associated with the classification model. This will not only give us confidence in the training process and prove that the model learned relevant features but also show the potential for weak localization tasks.
Related Work
Since 2012 and the success of AlexNet on Imagenet Challenge [4] , deep CNN have provided high accuracy results in large range of different tasks. Over the years, several architectures have been given a lot of attention. For example, Resnet-101 [5] proposes to use skipped connections over blocks to avoid unlearning on more abstract features spaces.
Previous works have applied CNN models to the Herlev data set using binary normal and abnormal categories. In [11] they reach a 0.78 F1 scoring using a support vector machine. In [12] they use a unsupervisely trained Feature Selection model after a CNN feature extractor to reach a F1 score of 0.90 and an accuracy of 94%. In [6, 7] , they used, respectively, an Alexnetlike and a Resnet architecture and trained them on Herlev dataset using normal vs abnormal to provide a model that reaches binary classification accuracy of 98.3%.
3 Herlev Severity Classification using Regression Constraint
Herlev Dataset
The Herlev Dataset is a cytology image set composed of 917 images gathered in 7 classes : normal columnar, normal intermediate, normal superficial, light dysplastic, moderate dysplastic, severe dysplastic, and carcinoma in situ. The three first FIGURE 1 -Resnet-101 confusion matrix on Herlev severity test set classes belong to the category of normal cells and the last four are abnormal ones (in order of severity, carcinoma in situ hinting at the presence of an actual cancer). Images are between 50 and 400 pixels wide. Previous work processed the set in a binary classification problem of normal vs abnormal classes. Here, we merged normal images into a single class in order to study the medical severity only, thus building a 5 classes dataset, we call Herlev severity consisting in : normal, light dysplastic, moderate dysplastic, severe dysplastic and carcinoma in situ.
Herlev Severity
This section descibes three pipelines that can be used to train a severity model and the motivation that led to them.
Classification Pipeline
We started by retraining a Resnet-101 model pretrained on ImageNet [10] on Herlev severity dataset. The computed performances were a mean AUC of 0.9, with the highest AUC being 0.95 on the carcinoma in situ class and lowest being 0.87 on severe dysplastic with an overall accuracy of 70.1%, a binary (normal/abnormal) accuracy of 90.8% and a binary F1 score of 0.94.
From the confusion matrix shown in Figure 1 , we see that the model tends to misclassify images from the normal class and most severe classes (severe dysplastic and carcinoma in situ). This was already reported in [6] and identified to be due to the visual similarities between normal columnar and carcinoma in situ cells. Obviously, missing a potential highly abnormal diagnonis is something to avoid. Similarly, due to the fact that 93% of pap smears are normal during routine diagnonis, misclassifying normal cells would require a additional action by the attending cytotechnicians.
Regression Pipeline
Since the WHO classification used in the Herlev set have an order of severity, this task can be interpreted as a regression problem. Regression loss will oblige the network to focus on how to differentiate normal samples from malignant ones. We relabel Herlev samples using a score from 1 (for normal ones) to 5 (for carcinoma ones) and use a mean square error as loss to optimize. Thus, we retrain the exact same Resnet-101 architecture replacing, to have a single score output, the softmax layer by a fully connected layer. Figure 2 shows the distribution of scores predicted on the test set and highlights that the model succeeded in assigning scores regarding maligancy. Most importantly, it does not mis-classify any normal samples or carcinoma in situ samples with each other. A further point to note from the confusion matrix ( Figure  3 ) deriving from this distribution, this model does more misclassifications than the categorical model, with an accuracy of 60.6%, however these misclassifcation are less severe in the scope due to their relative prognosis distance. This is can be more easily displayed by the overall MSE of 0.58 over the test set. The binary accuracy was of 91.8% and the F1 score was 0.95.
FIGURE 4 -Regression Constraint applied to Classifier

Classification + Regression Pipeline
While the regression loss was more adapted than a classification (cross entropy) loss to the severity task, it nonetheless did not improve the performances per class. In this section we combine the strength of both approaches into a single architecture. Figure 4 shows the additional layer to the classification architecture. We simply sum the cross entropy loss and the MSE loss. This would be equivalent to weighting loss regarding the distance between the ground truth class index and the predicted class index. We turn probabilities given by the softmax layer into a score using a fixed weights fully connected layer corresponding to the class score (or class index).
Noting p = (p 1 , . . . , p 5 ) these class probability neurons, our loss finally reads L(x) = CE(p; y x ) + (y x − 4 i=0 (i + 1).p i ) 2 where x is an image, y x the label (one hot for cross-entropy and score for the regression constraint) and CE is the cross-entropy loss.
On Figure 5 and Figure 6 , we can see that our Resnet-101, Classifier + Regressor, makes less misclassifications than the classifier and lower MSE than the regressor. Thus, we have an architecture performing on classification task (mean AUC = 0.94) and on scoring severity task (average MSE = 0.51). What is particularly appreciated here is that the 'extreme' classes ('normal' and 'carcinoma in situ') have the best AUC (respectively 0.98 and 0.97). The overall accuracy of the order of 74.5% and the binary accuracy was 94% with an F1 score of 0.96. Figure 7 shows the AUC distribution per class obtained training the classifier pipeline and the classifier + regressor pipeline on 4 random folds. It brings to the fore how the regression loss does not change much on the light dysplastic, moderate dysplastic and severe dysplastic classes but improves 'extreme' cases especially 'normal' samples that were really impacted by the ressemblance between 'normal columnar' and 'carcinoma in situ' samples. Understanding how our trained model predicts the severity of new cells is an important step in validating its use. We need a method that provides meaningful explanations, which ideally are related to the cytomorphological features and used by cytotechnians and doctors during day-to-day routine. Gradient based methods give the attribution to the classification associated with each input feature given to the model, in the case of digital images of cytology slides, the image pixels. This allows us to identify and localized regions that contribute to the severity of the diagnosis. Integrated Gradient [8] is of particular interest due to its model agnosticity and its baseline comparision.
Pipeline Comparisons
In this section we are going to use an attribution method to understand what has been learned by our models and on what cytomorphological features it relies to assign a degree of malignancy. The Bethesda guidelines [9] states that the main cytomorphological features used to determine the severity are mostly based on nucleus, we thus would expect the attribution to be in the nucleus region.
Integrated Gradient For the attribution we utilize a model agonistic methods, the integrated gradient. As with most attribution methods it relies on the comparision between the image and baseline (that is representative of the absence of the class of the image) and computation of the gradient to the image. The attribution map, Am(x i ; F, x ) for an image x gives the contribution of i − th pixel given a model F and baseline image x , Am(x i ; F, x ) = (x i − x i ). Baseline Design What we are interested in here is how our model predicts the malignancy (i.e. regression result), this is why we will try the Integrated Gradient method on malignant samples i.e. dysplastic and carcinoma in situ samples. An obvious abscence of object in Pap tests context is a white image (since background of pap smears slides is white). Figure 8 shows examples of the attribution map from integrated gradient method, along with the annotated cytology features of the associated the images. This highlights that the malignancy scoring seem to be mainly due to the nucleus.
Qualitative Results
Quantitative Results Here we make use of the annotation masks present in the Herlev set to create specific attribution metrics. Given their role in the different consensus and guidelines, we measure the amount of attribution within the nucleus and cytoplasm compared to total attribution (respectively denoted as At N and At C ), these contributions are given by, where N and C, refer to the nucleus and cytoplasm pixels respectively and Am is the attribution map defined before. In order to understand how much each region contributes to the model's prediction, we also compute the ratio of nucleus and cytoplasm attribution. Figure 9 shows the distribution for At N , At C , and their ratio for each severity class. It emphasises the relevance of the nucleus over the cytoplasm for the model as the severity increases. Particularly, in the case of carcinoma in situ, the nucleus contributes 2 times more than when classifying a normal case.
Conclusion
In this work, we have shown that a proper loss design, based on the final goal of the medical exam under study, one can construct a model that differentiates properly between normal and abnormal cells reaching a severity accuracy of 74.5%, a binary accuracy of 96.7% was achieved along wiht a F1 score of 0.95. Furthermore, we adapted an attribution method that can be used by doctors to check the relevance of the network's decision. These two contributions are essential in the construction of an automatic diagnostic assistance method that can be trusted and accepted by doctors.
